Issa and Chinmay cover Eli Lilly's acquisitions in 1st Half of 2026.
Eli Lilly has spent nearly $32B for 13 companies so far this year. These include Centessa Pharmaceuticals, Kelonia Therapeutics, Ventyx Biosciences, and AtaiBeckley.
Be sure to listen through the end for the addition on Merida Biosciences, and other latest acquisitions